|
Steven R. Foland Joins the Board
of Directors of VeriChip Corporation
DELRAY BEACH, FL – February
25, 2008 –VeriChip Corporation (NASDAQ: CHIP), a provider of RFID
systems for healthcare and patient-related needs, today announced it
has added Steven R. Foland to its Board of Directors. Foland is the
former managing director and head of investment banking at Merriman
Curhan Ford & Co, the lead underwriter of VeriChip’s initial public
offering which was completed in February 2007. Foland, who began his
career as an attorney, brings approximately 15 years of investment
banking experience to VeriChip with firms including Morgan Stanley
and Credit Suisse.
About VeriChip
VeriChip Corporation, headquartered in
Delray Beach, Florida, develops, markets and sells radio frequency
identification, or RFID, systems used to identify, locate and
protect people and assets. VeriChip's goal is to become the leading
provider of RFID systems for people in the healthcare industry. The
Company recently began marketing its VeriMed(TM) Patient
Identification System, a passive RFID system for rapidly and
accurately identifying people who arrive in an emergency room and
are unable to communicate. This system uses the first
human-implantable passive RFID microchip, the implantable VeriChip(TM),
cleared for medical use in October 2004 by the United States Food
and Drug Administration.
For more information on VeriChip, please
call 1-800-970-2447, or email info@verichipcorp.com. Additional
information can be found online at
http://www.verichipcorp.com.
Statements about the Company's future expectations, including future
revenues and earnings, and all other statements in this press
release other than historical facts are "forward-looking statements"
within the meaning of Section 27A of the Securities Act of 1933,
Section 21E of the Securities Exchange Act of 1934, and as that term
is defined in the Private Litigation Reform Act of 1995. Such
forward-looking statements involve risks and uncertainties and are
subject to change at any time, and the Company's actual results
could differ materially from expected results. The Company
undertakes no obligation to update forward-looking statements to
reflect subsequently occurring events or circumstances.
###
CONTACTS:
Dan Schustack
CEOcast
212-732-4300
dschustack@ceocast.com
Allison Tomek
VeriChip
Corporation
(561) 805-8008
atomek@adsx.com
Back
|
